​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 60.92% institutional investors, 1.84% insiders, and 37.24% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.81% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.17% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics60.92%1.84%37.24%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.17M11.81%$2.52B
Blackrock5.47M11.64%$1.74B
Vanguard group4.18M9.53%$2.03B
Avoro capital advisors2.02M4.48%$847.74M
Renaissance1.91M4.36%$930.29M
State street1.92M4.26%$805.98M
Wellington management group llp1.40M3.10%$586.38M
Geode capital management1.19M2.72%$580.24M
Aqr capital management975.44K2.19%$344.18M
Darwin global management748.55K1.66%$317.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management97.65K17.44%$40.93M
Tri locum partners lp122.19K11.77%$51.22M
Avoro capital advisors2.02M10.96%$847.74M
Darwin global management748.55K8.83%$317.62M
Eversept partners, lp253.22K7.32%$106.15M
Nepsis43.76K6.59%$21.32M
First turn management85.32K5.37%$35.77M
Palo alto investors lp58.19K4.51%$24.39M
Sofinnova investments190.63K4.37%$79.91M
Polaris capital management103.65K4.19%$50.50M

Top Buyers

HolderShares% AssetsChange
Darwin global management748.55K8.83%748.55K
Norges bank602.19K0.03%602.19K
Baillie gifford323.02K0.13%323.02K
Eversept partners, lp253.22K7.32%193.85K
Price t rowe associates inc /md/300.93K0.01%186.43K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---719.31K
Caisse de depot et placement du quebec98.14K0.07%-384.64K
Citigroup184.41K0.04%-367.06K
Avoro capital advisors2.02M10.96%-347.78K
Vaughan nelson investment management---328.78K

New Positions

HolderShares% AssetsChangeValue
Darwin global management748.55K8.83%748.55K$317.62M
Norges bank602.19K0.03%602.19K$293.42M
Baillie gifford323.02K0.13%323.02K$157.39M
Tri locum partners lp122.19K11.77%122.19K$51.22M
Orbimed advisors114.90K1.14%114.90K$48.17M

Sold Out

HolderChange
Financial synergies wealth advisors-1.00
Financial gravity asset management-1.00
Raleigh capital management-1.00
Opal wealth advisors-2.00
Cva family office-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025589-21.05%26,681,650-34.76%600.74%320-4.76%186-33.33%
Sep 30, 20257085.20%40,294,923-2.97%891.05%319-10.64%26425.71%
Jun 30, 20256810.59%43,719,199-1.26%961.00%3584.99%214-4.89%
Mar 31, 2025670-2.33%43,709,344-0.77%971.00%338-9.38%2236.70%
Dec 31, 2024628-1.10%59,260,45237.20%1321.42%3408.63%191-15.49%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.39M3.17%-16.09K
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Total Stock Mkt Idx Inv1.36M3.10%3.01K
Vanguard Small Cap Index975.34K2.23%-128.00
Vanguard Health Care Inv974.74K2.22%92.19K
Vanguard Small Cap Value Index Inv626.19K1.43%-4.74K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
Vanguard Institutional Extnd Mkt Idx Tr464.91K1.06%1.35K
SPDR® S&P Biotech ETF424.26K0.94%945.00
Invesco S&P MidCap Quality ETF368.42K0.84%-1.57K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 25, 2026CAUSEY CHRISTOPHER-Sell$520.00K
Feb 23, 2026BENKOWITZ MICHAEL PRESIDENT AND COOSell$2.39M
Feb 19, 2026MAHON PAUL A EVP & GENERAL COUNSELSell$366.39K
Feb 19, 2026MAHON PAUL A EVP & GENERAL COUNSELSell$290.36K
Feb 19, 2026MAHON PAUL A EVP & GENERAL COUNSELSell$136.29K

Insider Transactions Trends

DateBuySell
2026 Q1-96
2025 Q4-383
2025 Q3-150
2025 Q2-61
2025 Q1-145

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 60.92%, followed by 1.84% insiders and 37.24% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 382.11%, which United Therapeutics falls below.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.17M shares, 11.81%), Blackrock (5.47M shares, 11.64%), and Vanguard group (4.18M shares, 9.53%). Together, they hold 32.98% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.44% of its assets in 97.65K United Therapeutics shares, valued at 40.93M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.17% of its total shares outstanding invested in 1.39M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools